{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:13:55Z","timestamp":1788984835704,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13555-026-01860-5","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:44:27Z","timestamp":1784799867000},"page":"4501-4518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Patterns and Burden of Atopic Dermatitis in Adults in the United Arabic Emirates, Saudi Arabia, Kuwait, Qatar and Turkey: A Real-World Study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-8228","authenticated-orcid":false,"given":"Peter","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elrayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soniya","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soydan","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufaddal","family":"Alaithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Al-Breiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Fatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"B\u00fclb\u00fcl Ba\u015fkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atlal","family":"Al-Lafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"7","key":"1860_CR1","first-page":"1","volume":"3","author":"T Mahnashi","year":"2017","unstructured":"Mahnashi T, Haddadi Y, Yassin A. Epidemiology of atopic dermatitis among children in Jazan Region, Saudi Arabia. Epidemiology. 2017;3(7):1\u20136.","journal-title":"Epidemiology"},{"key":"1860_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144675","author":"O Mahmoud","year":"2023","unstructured":"Mahmoud O, Yosipovitch G, Attia E. Burden of disease and unmet needs in the diagnosis and management of atopic dermatitis in the Arabic population of the Middle East. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12144675.","journal-title":"J Clin Med"},{"key":"1860_CR3","doi-asserted-by":"publisher","unstructured":"Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105(2):99\u2013106; quiz 7\u20139, 17. https:\/\/doi.org\/10.1016\/j.anai.2009.10.002","DOI":"10.1016\/j.anai.2009.10.002"},{"key":"1860_CR4","unstructured":"Schwartz RA. Pediatric atopic dermatitis clinical presentation 2023. https:\/\/emedicine.medscape.com\/article\/911574-clinical. Accessed 9 April 2026"},{"issue":"5","key":"1860_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/ACI.0b013e32830ebb70","volume":"8","author":"BB Obeng","year":"2008","unstructured":"Obeng BB, Hartgers F, Boakye D, Yazdanbakhsh M. Out of Africa: what can be learned from the studies of allergic disorders in Africa and Africans? Curr Opin Allergy Clin Immunol. 2008;8(5):391\u20137. https:\/\/doi.org\/10.1097\/ACI.0b013e32830ebb70.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"1860_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/21556660.2019.1619570","volume":"8","author":"E Kowalska-Ol\u0119dzka","year":"2019","unstructured":"Kowalska-Ol\u0119dzka E, Czarnecka M, Baran A. Epidemiology of atopic dermatitis in Europe. J Drug Assess. 2019;8(1):126\u20138.","journal-title":"J Drug Assess"},{"issue":"3","key":"1860_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13555-023-00891-6","volume":"13","author":"A Ammoury","year":"2023","unstructured":"Ammoury A, Ameen A, El Sayed MH, Al-Khenaizan S, Hassan N, Ghoubar M. Patterns of clinical management of atopic dermatitis: a survey of three physician specialties in the Middle East. Dermatol Ther. 2023;13(3):769\u201385. https:\/\/doi.org\/10.1007\/s13555-023-00891-6.","journal-title":"Dermatol Ther"},{"issue":"7","key":"1860_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039803","volume":"7","author":"IA Deckers","year":"2012","unstructured":"Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990\u20132010: a systematic review of epidemiological studies. PLoS ONE. 2012;7(7):e39803. https:\/\/doi.org\/10.1371\/journal.pone.0039803.","journal-title":"PLoS ONE"},{"issue":"4","key":"1860_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jaci.2007.11.004","volume":"121","author":"H Williams","year":"2008","unstructured":"Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121(4):947-54.e15. https:\/\/doi.org\/10.1016\/j.jaci.2007.11.004.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1860_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100724","volume":"16","author":"J Maspero","year":"2023","unstructured":"Maspero J, De Paula Motta Rubini N, Zhang J, et al. Epidemiology of adult patients with atopic dermatitis in AWARE 1: a second international survey. World Allergy Organ J. 2023;16(3):100724. https:\/\/doi.org\/10.1016\/j.waojou.2022.100724.","journal-title":"World Allergy Organ J"},{"issue":"2","key":"1860_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13555-019-0285-2","volume":"9","author":"KAM Al-Afif","year":"2019","unstructured":"Al-Afif KAM, Buraik MA, Buddenkotte J, et al. Understanding the burden of atopic dermatitis in Africa and the Middle East. Dermatol Ther (Heidelb). 2019;9(2):223\u201341. https:\/\/doi.org\/10.1007\/s13555-019-0285-2.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"1860_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/exd.13514","volume":"27","author":"BP Kaufman","year":"2018","unstructured":"Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups-variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340\u201357. https:\/\/doi.org\/10.1111\/exd.13514.","journal-title":"Exp Dermatol"},{"issue":"4","key":"1860_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13555-019-00332-3","volume":"9","author":"YI Lopez Carrera","year":"2019","unstructured":"Lopez Carrera YI, Al Hammadi A, Huang YH, Llamado LJ, Mahgoub E, Tallman AM. Epidemiology, diagnosis, and treatment of atopic dermatitis in the developing countries of Asia, Africa, Latin America, and the Middle East: a review. Dermatol Ther (Heidelb). 2019;9(4):685\u2013705. https:\/\/doi.org\/10.1007\/s13555-019-00332-3.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1860_CR14","unstructured":"Bolognia JL, Jorizzo JL, Rapini RP, et al., editors. Dermatology. 2nd ed. St Louis (MO): Mosby; 2008."},{"issue":"5","key":"1860_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","volume":"65","author":"SY Chu","year":"2011","unstructured":"Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5):949\u201356. https:\/\/doi.org\/10.1016\/j.jaad.2010.08.032.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1860_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.det.2017.02.012","volume":"35","author":"A Mei-Yen Yong","year":"2017","unstructured":"Mei-Yen Yong A, Tay YK. Atopic dermatitis: racial and ethnic differences. Dermatol Clin. 2017;35(3):395\u2013402. https:\/\/doi.org\/10.1016\/j.det.2017.02.012.","journal-title":"Dermatol Clin"},{"issue":"4","key":"1860_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1525-1470.2012.01740.x","volume":"29","author":"V Vachiramon","year":"2012","unstructured":"Vachiramon V, Tey HL, Thompson AE, Yosipovitch G. Atopic dermatitis in African American children: addressing unmet needs of a common disease. Pediatr Dermatol. 2012;29(4):395\u2013402. https:\/\/doi.org\/10.1111\/j.1525-1470.2012.01740.x.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"1860_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2340\/00015555-0867","volume":"90","author":"HL Tey","year":"2010","unstructured":"Tey HL, Yosipovitch G. Itch in ethnic populations. Acta Derm Venereol. 2010;90(3):227\u201334. https:\/\/doi.org\/10.2340\/00015555-0867.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1860_CR19","first-page":"38","volume":"2","author":"S Scaria","year":"2011","unstructured":"Scaria S, James E, Dharmaratnam A. Epidemiology and treatment pattern of atopic dermatitis in patients attending a tertiary care teaching hospital. Int J Res Pharm Sci. 2011;2(1):38\u201344.","journal-title":"Int J Res Pharm Sci"},{"issue":"1","key":"1860_CR20","first-page":"108","volume":"28","author":"F Agboola","year":"2022","unstructured":"Agboola F, Atlas SJ, Brouwer E, et al. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value: a summary from the Institute for Clinical and Economic Review\u2019s New England Comparative Effectiveness Public Advisory Council. J Manag Care Spec Pharm. 2022;28(1):108\u201314.","journal-title":"J Manag Care Spec Pharm"},{"issue":"14","key":"1860_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s40265-021-01583-1","volume":"81","author":"S Duggan","year":"2021","unstructured":"Duggan S. Tralokinumab: first approval. Drugs. 2021;81(14):1657\u201363. https:\/\/doi.org\/10.1007\/s40265-021-01583-1.","journal-title":"Drugs"},{"issue":"11","key":"1860_CR22","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: Disease-Specific Programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372. https:\/\/doi.org\/10.1185\/03007990802457040.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"1860_CR23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on disease specific programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"1860_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352","volume":"6","author":"SM Babineaux","year":"2016","unstructured":"Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6(8):e010352. https:\/\/doi.org\/10.1136\/bmjopen-2015-010352.","journal-title":"BMJ Open"},{"key":"1860_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s120101","author":"V Higgins","year":"2000","unstructured":"Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type\u00a02 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes Targets Ther. 2000. https:\/\/doi.org\/10.2147\/dmso.s120101.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"12","key":"1860_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","volume":"140","author":"CR Charman","year":"2004","unstructured":"Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective. Arch Dermatol. 2004;140(12):1513\u20139. https:\/\/doi.org\/10.1001\/archderm.140.12.1513.","journal-title":"Arch Dermatol"},{"issue":"6","key":"1860_CR27","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/bjd.12590","volume":"169","author":"C Charman","year":"2013","unstructured":"Charman C, Venn A, Ravenscroft J, Williams H. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol. 2013;169(6):1326\u201332.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1860_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"1860_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1365-2133.2008.08832.x","volume":"159","author":"MK Basra","year":"2008","unstructured":"Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994\u20132007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997\u20131035. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08832.x.","journal-title":"Br J Dermatol"},{"key":"1860_CR30","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide.v3 2019. https:\/\/euroqol.org\/publications\/user-guides. Accessed 9 April 2026."},{"issue":"4","key":"1860_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40273-021-01100-y","volume":"40","author":"S Al Shabasy","year":"2022","unstructured":"Al Shabasy S, Abbassi M, Finch A, Roudijk B, Baines D, Farid S. The EQ-5D-5L valuation study in Egypt. Pharmacoeconomics. 2022;40(4):433\u201347. https:\/\/doi.org\/10.1007\/s40273-021-01100-y.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"1860_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.clinthera.2008.02.016","volume":"30","author":"MC Reilly","year":"2008","unstructured":"Reilly MC, Gerlier L, Brabant Y, Brown M. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn\u2019s disease. Clin Ther. 2008;30(2):393\u2013404. https:\/\/doi.org\/10.1016\/j.clinthera.2008.02.016.","journal-title":"Clin Ther"},{"issue":"3","key":"1860_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/DER.0000000000000895","volume":"33","author":"JM Hanifin","year":"2022","unstructured":"Hanifin JM, Baghoomian W, Grinich E, Leshem YA, Jacobson M, Simpson EL. The eczema area and severity index\u2014a practical guide. Dermatitis. 2022;33(3):187\u201392.","journal-title":"Dermatitis"},{"key":"1860_CR34","doi-asserted-by":"crossref","unstructured":"Gkalpakiotis S, Kannenberg S, Kingo K, et al. Real-world clinical, psychosocial, and economic burden of atopic dermatitis: results from the ESSENTIAL AD multicountry study. Dermatol Ther. 2024;14(5):1173\u201387.","DOI":"10.1007\/s13555-024-01146-8"},{"issue":"12","key":"1860_CR35","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s13555-022-00819-6","volume":"12","author":"AN Fasseeh","year":"2022","unstructured":"Fasseeh AN, Elezbawy B, Korra N, et al. Burden of atopic dermatitis in adults and adolescents: a systematic literature review. Dermatol Ther (Heidelb). 2022;12(12):2653\u201368. https:\/\/doi.org\/10.1007\/s13555-022-00819-6.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"1860_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13555-022-00857-0","volume":"13","author":"B Elezbawy","year":"2023","unstructured":"Elezbawy B, Fasseeh AN, Fouly E, et al. Humanistic and economic burden of atopic dermatitis for adults and adolescents in the Middle East and Africa region. Dermatol Ther. 2023;13(1):131\u201346.","journal-title":"Dermatol Ther"},{"issue":"14","key":"1860_CR37","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.3390\/jcm12144675","volume":"12","author":"O Mahmoud","year":"2023","unstructured":"Mahmoud O, Yosipovitch G, Attia E. Burden of disease and unmet needs in the diagnosis and management of atopic dermatitis in the Arabic population of the Middle East. J Clin Med. 2023;12(14):4675.","journal-title":"J Clin Med"},{"issue":"S1","key":"1860_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.2008","volume":"33","author":"SM Khaled","year":"2024","unstructured":"Khaled SM, Al-Abdulla M, Tulley I, Al-Thani SM, Woodruff PW. Qatar\u2019s national mental health study\u2014the world mental health Qatar. Int J Methods Psychiatr Res. 2024;33(S1):e2008.","journal-title":"Int J Methods Psychiatr Res"},{"key":"1860_CR39","unstructured":"Ministry of Health. National Saudi guidelines for the management of atopic dermatitis. https:\/\/www.moh.gov.sa\/en\/Ministry\/MediaCenter\/Publications\/Documents\/Atopic-Dermatitis-Guidelines.pdf. Accessed 20 June 2026."},{"issue":"8","key":"1860_CR40","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s13555-022-00777-z","volume":"12","author":"CE Kleyn","year":"2022","unstructured":"Kleyn CE, Barbarot S, Reed C, et al. Burden of moderate to severe atopic dermatitis in adults from France, Italy, and the UK: patient-reported outcomes and treatment patterns. Dermatol Ther (Heidelb). 2022;12(8):1947\u201365. https:\/\/doi.org\/10.1007\/s13555-022-00777-z.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1860_CR41","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S300402","author":"A-C Fougerousse","year":"2021","unstructured":"Fougerousse A-C, Jacobzone C, Mery-Bossard L, et al. Use of systemic medications for treating adult atopic dermatitis in France: results of a practice survey. Clin Cosmet Investig Dermatol. 2021. https:\/\/doi.org\/10.2147\/CCID.S300402.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"1860_CR42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","volume":"125","author":"Y Hongbo","year":"2005","unstructured":"Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Investig Dermatol. 2005;125(4):659\u201364.","journal-title":"J Investig Dermatol"},{"key":"1860_CR43","doi-asserted-by":"crossref","unstructured":"Devlin N, Parkin D, Janssen B, Devlin N, Parkin D, Janssen B, editors. An introduction to EQ-5D instruments and their applications. Methods for analysing and reporting EQ-5D data. Cham (CH): Springer; 2020. p.1\u201322.","DOI":"10.1007\/978-3-030-47622-9_1"},{"issue":"5","key":"1860_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"1860_CR45","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.7326\/M22-1460","volume":"175","author":"LM DeTora","year":"2022","unstructured":"DeTora LM, Toroser D, Sykes A, et al. Good publication practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2022;175(9):1298\u2013304. https:\/\/doi.org\/10.7326\/M22-1460.","journal-title":"Ann Intern Med"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01860-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:21:17Z","timestamp":1788981677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01860-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01860-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Peter Anderson, Jenny Austin and James Piercy are employees of Adelphi Real World. Mohamed Elrayes, Soniya Rai, Soydan Ince and Mufaddal Alaithan are employees and shareholders of Eli Lilly and Company. Martin Steinhoff has served on advisory boards for AbbVie, Janssen, Sanofi\/Regeneron, Pfizer, Eli Lilly, Galderma, Leo, MenloTx, Novartis, Union Tx, as consultant\/speaker for AbbVie, Amgen, Novartis, Janssen, Pfizer, Eli Lilly, Sanofi\/Regenereon, Maruho, MenloTx, Union Tx, Galderma, Leo, and has received research funding from Galderma, AbbVie, Leo, Pfizer, Novartis, Sanofi, Genetech, Maruho, Mitsubishi. Mohammed Fatani has served on the advisory boards for Leo Pharma, AbbVie, Pfizer, and Eli Lilly, and as a paid speaker for Eli Lilly and AbbVie. Emel B\u00fclb\u00fcl Ba\u015fkan has served as a speaker for Novartis, Janssen, and Eli Lilly. Atlal Al-Lafi has served on advisory boards and as a speaker for Sanofi, AbbVie, Eli Lilly, NewBridge, GSK, Pfizer, Johnson & Johnson, and Novartis. She has also participated in research and publications in collaboration with AbbVie, Sanofi, and more recently, Eli Lilly. Fatimah Al-Breiki has no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The DSP fulfils the definition of a market research survey under the EphMRA Code of Conduct and is therefore conducted in accordance with market research, rather than clinical, guidelines. Market research surveys are exempt from requiring institutional review board (IRB) approval; however, the Pearl IRB conducted a methodological review of the atopic dermatitis DSP and provided an exemption (#22-ADRW-154). The DSP was conducted in compliance with the Helsinki Declaration of 1964, and its later amendments.\u00a0Freely given, specific and informed consent was obtained from each respondent to take part in the DSP and for the processing of their personal data. All data provided by dermatologists and patients were anonymized.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}